COL12A1 and neoplasm: No statistically significant difference in prognosis was obtained in GEO-deposed patient tumor samples with high and low expressions for LUM (0.056), LYZ (0.18), HBB (0.095), EFEMP1 (0.127), and COL12A1 (0.25) markers.